These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14515013)

  • 1. The relationship between red blood cell Na/K-ATPase activities and diabetic complications in patients with type 2 diabetes mellitus.
    Koc B; Erten V; Yilmaz MI; Sonmez A; Kocar IH
    Endocrine; 2003 Aug; 21(3):273-8. PubMed ID: 14515013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of diabetic neuropathy with Na/K ATPase gene polymorphism.
    Vague P; Dufayet D; Coste T; Moriscot C; Jannot MF; Raccah D
    Diabetologia; 1997 May; 40(5):506-11. PubMed ID: 9165217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
    Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D; Gallice P; Pouget J; Vague P
    Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hypoglutathionemia with reduced Na+/K+ ATPase activity in type 2 diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Tara C; Rema M; Mohan V
    Mol Cell Biochem; 2006 Jan; 282(1-2):169-76. PubMed ID: 16317524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
    Shahid SM; Mahboob T
    Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
    Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
    Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Na/K ATPase ouabain binding sites in red blood cells of patients with insulin-dependent diabetes and healthy north African control subjects: relationship with diabetic neuropathy.
    Raccah D; Dadoun F; Coste T; Vague P
    Horm Metab Res; 1996 Mar; 28(3):128-32. PubMed ID: 8926011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between neuropathy, hypertension and red blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus.
    Jannot MF; Raccah D; Dufayet de la Tour D; Coste T; Gouvernet J; Vague P
    Diabetes Metab; 1999 Mar; 25(1):35-42. PubMed ID: 10335422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic hyperglycemia and vanadate treatment on erythrocyte Na/K-ATpase and Mg-ATpase in streptozotocin diabetic rats.
    Totan AR; Greabu M
    Acta Pol Pharm; 2002; 59(4):307-11. PubMed ID: 12403306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of nerve Na+,K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy.
    Scarpini E; Bianchi R; Moggio M; Sciacco M; Fiori MG; Scarlato G
    J Neurol Sci; 1993 Dec; 120(2):159-67. PubMed ID: 8138805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
    Mimura M; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.
    De La Tour DD; Raccah D; Jannot MF; Coste T; Rougerie C; Vague P
    Diabetologia; 1998 Sep; 41(9):1080-4. PubMed ID: 9754827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sodium and potassium pump activity and number in diabetic erythrocytes.
    Nagamatsu S; Inoue N; Murakawa S; Matsui H
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):69-74. PubMed ID: 3004092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients.
    Jannot MF; Raccah D; De La Tour DD; Coste T; Vague P
    Metabolism; 2002 Mar; 51(3):284-91. PubMed ID: 11887161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic factors, Na K ATPase activity and neuropathy in diabetics].
    Vague P; Dufayet D; Lamotte MF; Mouchot C; Raccah D
    Bull Acad Natl Med; 1997 Dec; 181(9):1811-21; discussion 1821-3. PubMed ID: 9611401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of Na(+)-K(+)-ATP ase activity in erythrocyte membrane from diabetic retinopathy patients].
    He J; Qiu Y; Zhou X
    Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):421-3. PubMed ID: 11877243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.